Project Grant R15GM157702

Award Date 9/17/24
Completion Date 8/31/27
Dollars Obligated $458K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Dorchester, MA 02125, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $1,590,000 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) program to the Massachusetts Institute of Technology (MIT) to advance research on computational modeling and machine learning for enzymatic and biomimetic C-H activation. Over the 5-year project period from August 2024 to May 2029, the PI will: 1) develop models for predicting regioselectivity in non-heme iron enzymes, 2) systematically...
The National Institute of General Medical Sciences (NIGMS) awarded a $694,875 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) federal grant program to Trustees of Boston University (Boston University Medical Campus). The grant, with a project period from February 1, 2025 to January 31, 2030, will support research to understand the molecular mechanisms that impart plasticity to G protein-coupled receptor (GPCR) and heterotrimeric G protein signaling. The research...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $455,940 to the University of Massachusetts Lowell to study the biophysical properties of intrinsically disordered proteins (IDPs) when confined to nanoscale environments. The research aims to reveal how the structural plasticity of IDPs is influenced by their localization and confinement on nanoparticle constructs, with the...
The National Institute of General Medical Sciences (NIGMS) awarded a $389,211 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Massachusetts (UMass) Amherst. The grant, which runs from July 2024 to June 2029, will fund research to investigate the biophysical and molecular mechanisms underlying a novel process of "meso-scale gap closure" in tissues undergoing epithelial-mesenchymal transition. The research aims to...
This $368,110 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to study the structures and properties of key enzymatic intermediates involved in oxygenase chemistry. The research aims to develop peptide-based synthetic models that can mimic the active sites and reactivity of non-heme iron and copper oxygenases, which are critical for metabolism, natural product...
This $151,080 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will be used to acquire a circular dichroism (CD) spectropolarimeter instrument by the University of Massachusetts Dartmouth. The instrument will enhance the university's biomedical research and education capabilities in areas such as investigating the structures of chiral nanoparticles and biomolecules. This specialized equipment...
The National Institute of General Medical Sciences (NIGMS) awarded a $358,012 Project Grant (CFDA 93.859 Biomedical Research and Research Training) to the Massachusetts Institute of Technology (MIT) with a start date of Jul 25, 2024 and an end date of Jan 18, 2027. The grant will fund research to develop a mild and efficient strategy for stereochemical editing of quaternary stereocenters guided by enantioselective recombination of carbon-carbon bonds. The proposed research aims to establish dual...
This federal Project Grant award of $453,750.00 was issued on April 16, 2025 by the National Institute of General Medical Sciences (NIGMS), which administers the Biomedical Research and Research Training (CFDA 93.859) program. The grant will support the development of innovative mass spectrometry-based proteomics pipelines to improve throughput, depth, and accuracy in profiling proteomes, post-translational modifications, and cysteine accessibility. The awardee, President and Fellows of...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) program, provides $444,262 to the Massachusetts Institute of Technology (MIT) over a period from June 1, 2025 to March 31, 2030. The funding supports the synthesis and applications of oligophosphate constructs, which are important for studying the role of phosphorylated biomolecules in human physiology, health, and medicine. Key...
This Project Grant award of $1,207,500.00 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program supports research to advance the understanding of drug absorption processes. The research aims to systematically evaluate the particle drifting effect and de-supersaturation kinetics, both of which are key factors influencing oral drug bioavailability. The project will develop mass transport models, in vitro...

The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant totaling $457,500.00 under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Massachusetts Boston. The grant, with a performance period from September 17, 2024 to August 31, 2027, aims to systematically identify chemical processes and reactions that show promise when initiated under high hydrostatic pressure (HHP) conditions. The research will involve a combination of theoretical calculations and experimental testing to build a reaction network and evaluate the extent to which HHP can enhance various chemical transformations, including the synthesis of active pharmaceutical ingredients (APIs) and other high-value building blocks. The goal is to leverage the availability of industrial-scale HHP equipment to develop new, scalable green chemistry processes that could benefit the pharmaceutical industry.

Generated 7/1/25, 2:52 AM